Furthermore, the administration of oral live L. rhamnosus GG (LGG) in conjunction with immune checkpoint therapy yields a substantial augmentation in the population of dendritic cells (DCs) that elicit the activation of CD8+ T cells and their subsequent recruitment into the tumor microenvironment. The gene discussed is CD8A; the disease is neoplasm.